Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
| ACG | Underwritten Rights Issue Prospectus Lodged with ASIC | PRICE SENSITIVE | 23/04/18 | |
| ACG | Oversubscribed Capital Raising to Fast Track New Strategy | PRICE SENSITIVE | 23/04/18 | |
| ACG | Trading Halt | PRICE SENSITIVE | 19/04/18 | |
| ACG | AtCor Announces First Steps in Major Strategic Repositioning | PRICE SENSITIVE | 14/03/18 | |
| ACG | Half Yearly Report and Accounts | PRICE SENSITIVE | 28/02/18 | |
| ACG | AtCor's XCEL device clinically validated in 3rd party study | PRICE SENSITIVE | 23/01/18 | |
| ACG | Chairman's address to 2017 AGM | PRICE SENSITIVE | 30/11/17 | |
| ACG Underwritten Rights Issue Prospectus Lodged with ASIC | |||
| 23/04/18 | PRICE SENSITIVE | ||
| ACG Oversubscribed Capital Raising to Fast Track New Strategy | |||
| 23/04/18 | PRICE SENSITIVE | ||
| ACG Trading Halt | |||
| 19/04/18 | PRICE SENSITIVE | ||
| ACG AtCor Announces First Steps in Major Strategic Repositioning | |||
| 14/03/18 | PRICE SENSITIVE | ||
| ACG Half Yearly Report and Accounts | |||
| 28/02/18 | PRICE SENSITIVE | ||
| ACG AtCor's XCEL device clinically validated in 3rd party study | |||
| 23/01/18 | PRICE SENSITIVE | ||
| ACG Chairman's address to 2017 AGM | |||
| 30/11/17 | PRICE SENSITIVE | ||
